ReviewMolecular biotechnology2026
DNA-Based Boolean Logic Gates for Molecular Computation and Biosensing: A Critical Review.
Review in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DNA-based Boolean logic gates represent a transformative platform in molecular computation, providing a bridge between biological processes. The field has advanced toward sophisticated designs incorporating spatiotemporal control. Distinguished by features such as massive parallelism, biocompatibility, energy efficiency, and programmability, DNA computing enables operations beyond the scope of silicon-based technologies. These qualities have enabled applications in biomedical diagnostics, autonomous biosensing, and therapeutic regulation. Furthermore, multi-layered circuit architectures, including neural network like designs, highlight the transition from basic proofs of concept to practical, application-oriented technologies. Key challenges remain particularly signal leakage, gate stability, scalability, and NOT gate constraints. Emerging solutions, such as photocaging for precise activation, enzyme-mediated processing for higher fidelity, and cost-effective array-based DNA synthesis, have improved reliability and scalability. Integration with artificial intelligence, machine learning, and bioelectronics is further advancing hybrid molecular electronic systems capable of coupling biological recognition with robust digital processing. Future progress depends on standardization, reproducibility, and economic scalability. The development of automated design frameworks, rigorous validation, and cost reduction strategies will be central to driving adoption. With immediate potential in diagnostics and environmental monitoring, DNA logic gates are shaping the foundation of molecular intelligence platforms.
Indexed as
Identifiers
42223865What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.